| Synthesis, Cytotoxicity, and Anti-Trypanosoma cruzi Activity of New Chalcones JC Aponte, M Verástegui, E Málaga, M Zimic, M Quiliano, AJ Vaisberg, ... Journal of medicinal chemistry 51 (19), 6230-6234, 2008 | 184 | 2008 |
| New salicylamide and sulfonamide derivatives of quinoxaline 1, 4-di-N-oxide with antileishmanial and antimalarial activities C Barea, A Pabón, D Castillo, M Zimic, M Quiliano, S Galiano, ... Bioorganic & medicinal chemistry letters 21 (15), 4498-4502, 2011 | 81 | 2011 |
| Trypanoside, anti-tuberculosis, leishmanicidal, and cytotoxic activities of tetrahydrobenzothienopyrimidines JC Aponte, AJ Vaisberg, D Castillo, G Gonzalez, Y Estevez, J Arevalo, ... Bioorganic & medicinal chemistry 18 (8), 2880-2886, 2010 | 60 | 2010 |
| Trypanocidal properties, structure–activity relationship and computational studies of quinoxaline 1, 4-di-N-oxide derivatives Y Estevez, M Quiliano, A Burguete, B Cabanillas, M Zimic, E Málaga, ... Experimental parasitology 127 (4), 745-751, 2011 | 59 | 2011 |
| Aryl piperazine and pyrrolidine as antimalarial agents. Synthesis and investigation of structure–activity relationships A Mendoza, S Pérez-Silanes, M Quiliano, A Pabón, S Galiano, ... Experimental parasitology 128 (2), 97-103, 2011 | 58 | 2011 |
| Novel antimalarial chloroquine-and primaquine-quinoxaline 1, 4-di-N-oxide hybrids: Design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies L Bonilla-Ramirez, A Rios, M Quiliano, G Ramirez-Calderon, ... European journal of medicinal chemistry 158, 68-81, 2018 | 46 | 2018 |
| New hydrazine and hydrazide quinoxaline 1, 4-di-N-oxide derivatives: In silico ADMET, antiplasmodial and antileishmanial activity M Quiliano, A Pabón, G Ramirez-Calderon, C Barea, E Deharo, S Galiano, ... Bioorganic & medicinal chemistry letters 27 (8), 1820-1825, 2017 | 39 | 2017 |
| ImmunoPEGliposomes for the targeted delivery of novel lipophilic drugs to red blood cells in a falciparum malaria murine model E Moles, S Galiano, A Gomes, M Quiliano, C Teixeira, I Aldana, P Gomes, ... Biomaterials 145, 178-191, 2017 | 37 | 2017 |
| Comprehensive virtual screening of 4.8 k flavonoids reveals novel insights into allosteric inhibition of SARS-CoV-2 MPRO G Jiménez-Avalos, AP Vargas-Ruiz, NE Delgado-Pease, ... Scientific Reports 11 (1), 1-19, 2021 | 36 | 2021 |
| Peruvian and globally reported amino acid substitutions on the Mycobacterium tuberculosis pyrazinamidase suggest a conserved pattern of mutations associated to pyrazinamide … M Zimic, P Sheen, M Quiliano, A Gutierrez, RH Gilman Infection, Genetics and Evolution 10 (2), 346-349, 2010 | 34 | 2010 |
| Mathematical algorithm for the automatic recognition of intestinal parasites A Alva, C Cangalaya, M Quiliano, C Krebs, RH Gilman, P Sheen, M Zimic PloS one 12 (4), e0175646, 2017 | 31 | 2017 |
| Docking and quantitative structure–activity relationship studies for 3-fluoro-4-(pyrrolo[2,1-f][1,2,4]triazin-4-yloxy)aniline, 3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy … J Caballero, M Quiliano, JH Alzate-Morales, M Zimic, E Deharo Journal of computer-aided molecular design 25 (4), 349-369, 2011 | 31 | 2011 |
| Exploring the scope of new arylamino alcohol derivatives: Synthesis, antimalarial evaluation, toxicological studies, and target exploration M Quiliano, A Mendoza, KY Fong, A Pabón, NE Goldfarb, I Fabing, ... International Journal for Parasitology: Drugs and Drug Resistance 6 (3), 184-198, 2016 | 23 | 2016 |
| Theoretical analysis of the neuraminidase epitope of the Mexican A H1N1 influenza strain, and experimental studies on its interaction with rabbit and human hosts PKR Loyola, R Campos-Rodriguez, M Bello, S Rojas-Hernandez, M Zimic, ... Immunologic research 56 (1), 44-60, 2013 | 21 | 2013 |
| Structure-Activity relationship in mutated pyrazinamidases from Mycobacterium tuberculosis M Quiliano, AH Gutierrez, RH Gilman, C López, W Evangelista, J Sotelo, ... Bioinformation 6 (9), 335, 2011 | 20 | 2011 |
| The in vivo antimalarial activity of methylene blue combined with pyrimethamine, chloroquine and quinine G Garavito, S Bertani, M Quiliano, A Valentin, I Aldana, E Deharo Memórias do Instituto Oswaldo Cruz 107 (6), 820-823, 2012 | 18 | 2012 |
| Outside‐binding site mutations modify the active site's shapes in neuraminidase from influenza A H1N1 L Tolentino‐Lopez, A Segura‐Cabrera, P Reyes‐Loyola, M Zimic, ... Biopolymers 99 (1), 10-21, 2013 | 17 | 2013 |
| Immunoinformatics prediction of linear epitopes from Taenia solium TSOL18 M Zimic, AH Gutiérrez, RH Gilman, C López, M Quiliano, W Evangelista, ... Bioinformation 6 (7), 271, 2011 | 17 | 2011 |
| A Complementary Mechanism of Bacterial mRNA Translation Inhibition by Tetracyclines V Barrenechea, M Vargas-Reyes, M Quiliano, P Milón Frontiers in Microbiology 12, 1431, 2021 | 15 | 2021 |
| Primaquine–quinoxaline 1, 4-di-N-oxide hybrids with action on the exo-erythrocytic forms of Plasmodium induce their effect by the production of reactive oxygen species L Bonilla-Ramírez, S Galiano, M Quiliano, I Aldana, A Pabón Malaria Journal 18 (1), 201, 2019 | 15 | 2019 |
